https://clinicaltrials.gov/ct2/show/NCT03556033
Study Type : Interventional
Estimated Enrollment : 15 participants
Allocation: Randomized
Intervention Model: Crossover Assignment
Masking: Quadruple (Participant, Care Provider, Investigator, Outcomes Assessor)
Primary Purpose: Treatment
Official Title: Effect of the SGLT-2 Inhibitor Dapagliflozin on Impaired Awareness of Hypoglycemia in Type 1 Diabetes
Actual Study Start Date : November 23, 2018
Estimated Primary Completion Date : December 2019
Estimated Study Completion Date : December 2019
